NCT05664958 - ESP Block for Post Cesarean Analgesia | Biotech Hunter

Enrollment

150

Participants

Timeline

Start Date

April 17, 2023

Primary Completion Date

November 9, 2023

Study Completion Date

November 9, 2023

Conditions

Cesarean Section Complications

Interventions

PROCEDURE

Erector Spinae Plane (ESP) Block

ESP Block with liposomal bupivacaine and immediate release bupivacaine

DRUG

bupivacaine liposome injectable suspension

133 mg liposomal bupivacaine per side.

DRUG

bupivacaine

20 ml bupivacaine 0.25% per side.

Trial Locations (1)

Duke University Hospital, Durham